Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.18
Delayed Data
As of May 26
 +0.03 / +0.37%
Today’s Change
5.70
Today|||52-Week Range
9.09
+33.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues163.0K353.0K610.0K611.0K
 
 
 
 
 
Cost of Goods Sold--489.0K186.0K--
 
 
 
Depreciation And Amortization1.0K1.0K1.0K1.0K
 
 
 
 
 
 
Operating ExpensesGross Income---137.0K423.0K--
 
 
 
General Expenses2.3M3.4M2.8M4.0M
 
 
 
 
 
Research And Development1.7M2.8M2.4M3.1M
 
 
 
 
 
Total Operating Expenses2.3M3.9M3.0M4.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.1M-3.5M-2.4M-3.4M
 
 
 
 
 
Other Expenses-23.0K-30.0K-24.0K-21.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.0M-3.4M-2.2M-3.2M
 
 
 
 
 
Income Taxes0.00-1.3M-400.0K0.00
 
 
 
Net Income-2.0M-4.8M-2.6M-3.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.1M13.2M13.2M13.3M
 
 
 
 
 
Shares To Calculate EPS Diluted13.1M13.2M13.2M13.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15---$0.20-$0.24
 
 
 
 
EPS Diluted-$0.15-$0.36-$0.20-$0.24